Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
The Netherlands is a country highly affected by the COVID-19 pandemic. In this study, Slot, Hogema and colleagues report a low SARS-CoV-2 seroprevalence one month into the outbreak and provide insights into virus exposure by region and age group when widespread non-pharmaceutical interventions are i...
Guardado en:
Autores principales: | Ed Slot, Boris M. Hogema, Chantal B. E. M. Reusken, Johan H. Reimerink, Michel Molier, Jan H. M. Karregat, Johan IJlst, Věra M. J. Novotný, René A. W. van Lier, Hans L. Zaaijer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/863a9c58df364edcbc4a6ef24499c75d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
por: Dianna L. Ng, et al.
Publicado: (2020) -
Hepatitis E virus seroprevalence among blood donors in southwest Switzerland.
por: Annatina Kaufmann, et al.
Publicado: (2011) -
Seroprevalence of Chikungunya (CHIK) Infection during Non Epidemic Periods in Chennai, Southern India
por: Kaliyamoorthy Kayalvili, et al.
Publicado: (2021) -
Seroprevalence of antibodies against Borrelia burgdorferi sensu lato in healthy blood donors in Romania: an update
por: Zsuzsa Kalmár, et al.
Publicado: (2021) -
Seroprevalence of hepatitis E virus in risk populations and blood donors in a referral hospital in the south of Brazil
por: Marisa Boff Costa, et al.
Publicado: (2021)